EMD-21231

Single-particle
4.6 Å
EMD-21231
3D View Gallery
Deposition: 22/01/2020
Map released: 12/08/2020
Last modified: 06/03/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-21231
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 6vl6 summary report (pdf.gz) Map and 6vl6 FULL report (pdf.gz)
EMICSS annotations (xml)

De novo designed tetrahedral nanoparticle T33_dn2 presenting BG505 SOSIP trimers

EMD-21231

Single-particle
4.6 Å
EMD-21231
3D View Gallery
Deposition: 22/01/2020
Map released: 12/08/2020
Last modified: 06/03/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: synthetic construct
Sample: De novo designed tetrahedral nanoparticle BG505 SOSIP-T33_dn2
Fitted models: 6vl6

Deposition Authors: Ward AB, Antanasijevic A
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.
Martin JT, Cottrell CA , Antanasijevic A, Carnathan DG, Cossette BJ, Enemuo CA, Gebru EH, Choe Y, Viviano F, Fischinger S , Tokatlian T , Cirelli KM, Ueda G , Copps J , Schiffner T, Menis S, Alter G , Schief WR , Crotty S, King NP, Baker D, Silvestri G, Ward AB, Irvine DJ
(2020) NPJ Vaccines , 5 , 72 - 72
PUBMED: 32802411
DOI: doi:10.1038/s41541-020-00223-1
ISSN: 2059-0105